SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Egea PF, Klaholz BP, Moras D. 2000. Ligand-protein interactions in nuclear receptors of hormones. FEBS Lett 476: 6267.
  • 2
    Katzenellenbogen JA, O'Malley BW, Katzenellenbogen BS. 1996. Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol Endocrinol 10: 119131.
  • 3
    Herbst A, Bern HE. 1981. Developmental Effects of Diethylstilbestrol (DES) in Pregnancy. Thieme-Stratton, New York, NY, USA.
  • 4
    Elsby R, Ashby J, Sumpter J, Brooks A, Pennie W, Maggs J, Lefevre P, Odum J, Beresford N, Paton D, Park BK. 2000. Obstacles to the prediction of estrogenicity from chemical structure: Assay-mediated metabolic transformation and the apparent promiscuous nature of the estrogen receptor. Biochem Pharmacol 60: 15191530.
  • 5
    Toppari J, Larsen JC, Christiansen P, Giwercman A, Grandjean P, Guillette LJ Jr, Jégou B, Jensen TK, Jouannet P, Keiding N, Leffers H, McLachlan JA, Meyer O, Müller J, Rajpert-De Meyts E, Scheike T, Sharpe R, Sumpter J, Skakkebæk NE. 1996. Male reproductive health and environmental xenoestrogens. Environ Health Perspect 104: 741803.
  • 6
    Kavlock RJ, Daston GP, DeRosa C, Fenner-Crisp P, Earl Gray L, Kaattari S, Lucier G, Luster M, Mac MJ, Maczka C, Miller R, Moore J, Rolland R, Scott G, Sheehan DM, Sinks T, Tilson HS. 1996. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: A report of the U.S. EPA–sponsored workshop. Environ Health Perspect 104: 715740.
  • 7
    Ankley GT, Giesy JP. 1998. Endocrine disruptors in wildlife: A weight of evidence perspective. In KendallR, DickersonR, SukW, GiesyJP, eds, Principles and Processes for Assessing Endocrine Disruption in Wildlife. SETAC, Pensacola, FL, USA, pp 349368.
  • 8
    Tyler CR, Jobling S, Sumpter JP. 1999. Endocrine disruption in wildlife: A critical review of the evidence. CRC Crit Rev Toxicol 28: 319361.
  • 9
    Purdom CE, Hardiman PA, Bye VJ, Eno NC, Tyler CR, Sumpter JP. 1994. Estrogenic effects of effluent from sewage treatment works. Chem Ecol 8: 275285.
  • 10
    Desbrow G, Routledge EJ, Brighty GC, Sumpter JP, Waldock M. 1998. Identification of estrogenic chemicals in STW effluent. 1. Chemical fractionation and in vitro biological screening. Environ Sci Technol 32: 15491558.
  • 11
    Jobling S, Sumpter JP. 1993. Detergent components in sewage effluent are weakly oestrogenic to fish: An in vitro study using rainbow trout (Oncorhynchus mykiss) hepatocytes. Aquat Toxicol 27: 361372.
  • 12
    U.S. Environmental Protection Agency. 1998. Endocrine disruptor screening and testing advisory committee (EDSTAC). Report 98. Office of Prevention, Pesticides and Toxic Substances, Washington, DC.
  • 13
    Schmieder P, Aptula A, Routledge E, Sumpter J, Mekenyan O. 2000. Estrogenicity of alkylphenolic compounds: A 3-D structure-activity evaluation of gene activation. Environ Toxicol Chem 19: 17271740.
  • 14
    Gao H, Katzenellenbogen J, Garg R, Hansch C. 1999. Comparative QSAR analysis of estrogen receptor ligands. Chem Rev 99: 723744.
  • 15
    Wiese TE, Polin L, Palomino B, Brooks SC. 1997. Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogues of 17β-estradiol: A 3-D QSAR study. J Med Chem 40: 36593669.
  • 16
    Mosselman S, Polman J, Dijkema R. 1996. ERβ: Identification and characterization of a novel human estrogen receptor. FEBS Lett 392: 4953.
  • 17
    Kuiper GG, Carlsson BO, Grandien K, Enmark E, Haggblad J, Nilsson SGJA. 1997. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and β. Endocrinology 138: 863870.
  • 18
    McDonnell DP. 1999. The molecular pharmacology of SERMs. Trends Endocrinol Metab 10: 301311.
  • 19
    Kim S-H, Katzenellenbogen JA. 2000. Triarylethylene bisphenols with a novel cycle are ligands for the estrogen receptor. Bioorg Med Chem Lett 8: 785793.
  • 20
    Hawkins M, Thornton J, Skipper J, Dotte A, Thomas P. 2000. Identification of a third distinct estrogen receptor and reclassification of estrogen receptors in teleosts. Proc Natl Acad Sci USA 97: 1075110756.
  • 21
    Levenson AS, Jordan VC. 1999. Selective oestrogen receptor modulation: Molecular pharmacology for the millennium. Eur J Cancer 35: 19741985.
  • 22
    Kraichely DM, Sun J, Katzenellenbogen JA, Katzenellenbogen BS. 2000. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor- and estrogen receptor-: Correlations with biological character and distinct differences among SRC coactivator family members. Endocrinology 141: 35343545.
  • 23
    Schmieder PK, Koleva Y, Mekenyan OG. 2002. A reactivity pattern for discrimination of ER agonism and antagonism based on 3-D molecular attributes. SAR/QSAR Environ Res 13: 353364.
  • 24
    Shi L, Fang H, Tong W, Wu J, Perkins R, Blair R, Branham W, Dial S, Moland C, Sheehan DM. 2001. QSAR models using a large diverse set of estrogens. J Chem Inf Comput Sci 41: 186195.
  • 25
    Hopfinger A, Tokarski J. 1997. Three-dimensional quantitative structure-activity relationship analysis. In CharifsonPS, ed, Practical Application of Computer–Aided Drug Design. Marcell-Dekker, New York, NY, USA.
  • 26
    Brzozowski AM, Pike ACW, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman LGGL, Gustafsson JA, Carlquist M. 1997. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389: 753758.
  • 27
    Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL. 1998. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95: 927937.
  • 28
    Ekena K, Weis KE, Katzenellenbogen JA, Katzenellenbogen BS. 1997. Different residues of the human estrogen receptor are involved in the recognition of structurally diverse estrogens and antiestrogens. J Biol Chem 272: 50695075.
  • 29
    Mori T, Sumiya S, Yokota H. 2000. Electrostatic interactions of androgens and progesterone derivatives with rainbow trout estrogen receptor. J Steroid Biochem Mol Biol 75: 129137.
  • 30
    Hansch C, Leo A, Hoekman D. 1995. Exploring QSAR. Hydrophobic, Electronic, and Steric Constants. American Chemical Society, Washington, DC.
  • 31
    Tong W, Lowis DR, Perkins R, Chen Y, Welsh WJ, Goddette DW, Heritage TW, Sheehan DM. 1998. Evaluation of quantitative structure-activity relationship methods for large-scale prediction of chemicals binding to estrogen receptor. J Chem Inf Comput Sci 8. 5A–I.
  • 32
    Walker JD, Fang H, Perkins R, Tong W. 2003. QSARs for EDPSD 2: The integrated 4-phase model. QSAR Combinatorial Science 22: 89105.
  • 33
    Cramer RI, Patterson D, Bunce J. 1988. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110: 59595967.
  • 34
    Xing L, Welsh WJ, Tong W, Perkins R, Sheehan DM. 1999. Comparison of estrogen receptor alpha and beta subtypes based on comparative molecular field analysis (CoMFA). SAR/QSAR Environ Sci 10: 215237.
  • 35
    Bradbury SP, Mekenyan OG, Ankley GT. 1996. Quantitative structure-activity relationships for polychlorinated hydroxybiphenyl estrogen receptor binding affinity: An assessment of conformer flexibility. Environ Toxicol Chem 15: 19451954.
  • 36
    Bradbury SP, Mekenyan OG, Ankley GT. 1998. The role of ligand flexibility in predicting biological activity: Structure-activity relationships for aryl hydrocarbon, estrogen and androgen receptor binding affinity. Environ Toxicol Chem 17: 1525.
  • 37
    Mekenyan O, Ivanov J, Karabunarliev S, Bradbury SP, Ankley GT, Karcher W. 1997. A computationally-based hazard identification algorithm that incorporates ligand flexibility. 1. Identification of potential androgen receptor ligands. Environ Sci Technol 31: 37023711.
  • 38
    Mekenyan O, Nikolova N, Karabunarliev S, Bradbury S, Ankley G, Hansen B. 1999. New developments in a hazard identification algorithm for hormone receptor ligands: COREPA-C. Quant Struct-Act Relat 18: 139153.
  • 39
    Bradbury S, Kamenska V, Schmieder P, Ankley G, Mekenyan O. 2000. A computationally-based identification algorithm for estrogen receptor ligands. Part I. Predicting hERα binding affinity. Toxicol Sci 58: 253269.
  • 40
    Mekenyan O, Kamenska V, Schmieder P, Ankley G, Bradbury S. 2000. A computationally-based identification algorithm for estrogen receptor ligands. Part II. Evaluation of a hERα binding affinity model. Toxicol Sci 58: 270281.
  • 41
    Eliel E. 1993. Chemistry in Three Dimensions. Springer, Berlin, Germany.
  • 42
    Ivanov JM, Karabunarliev SH, Mekenyan OG. 1994. 3DGEN: A system for an exhaustive 3D molecular design. J Chem Inf Comput Sci 34: 234243.
  • 43
    Anstead GM, Wilson SR, Katzenellenbogen JA. 1989. 2-Arylindenes and 2-arylindenones: Molecular structures and considerations in the binding orientation of unsymmetrical nonsteroidal ligands to the estrogen receptor. J Med Chem 32: 21632171.
  • 44
    Anstead GM, Carlson KE, Katzenellenbogen JA. 1997. The estradiol pharmacophore: Ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Steroids 62: 268303.
  • 45
    Wiese TE, Brooks SC. 1994. Molecular modeling of steroidal estrogens: Novel conformations and their role in biological activity. J Steroid Biochem Mol Biol 50: 6173.
  • 46
    Ivanov JM, Mekenyan OG, Bradbury SP, Schüürmann G. 1998. A kinetic analysis of the conformational flexibility of steroids. Quant Struct-Act Relat 17: 437449.
  • 47
    Waller CL, Oprea TI, Chae K, Park H-K, Korach KS, Laws SC, Wiese TE, Kelce WR, Gray LE Jr., 1996. Ligand-based identification of environmental estrogens. Chem Res Toxicol 9: 12401248.
  • 48
    Waller CL, Minor DL, McKinney JD. 1995. Using three-dimensional quantitative structure-activity relationships to examine estrogen receptor binding affinities of polychlorinated hydroxybiphenyls. Environ Health Perspect 103: 702707.
  • 49
    Kearsley SK, Smith GM. 1990. An alternative method for the alignment of molecular structure: Maximized electrostatic and steric overlap. Tetrahedron Computed Methodology 3: 615633.
  • 50
    Wang R, Gao Y, Lin L, Lai L. 1998. All orientation search and all-placement search in comparative molecular field analysis. J Mol Modeling 4: 276283.
  • 51
    Kuiper GG, Lemmon J, Carlsson B, Corton J, Safe S, van der Saag P, van der Burg B, Gustafsson JA. 1998. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139: 42524263.
  • 52
    Goldstein RA, Katzenellenbogen JA, Luthey-Schulten ZA, Seielstad DA, Wolynes PG. 1993. Three-dimensional model for the hormone binding domains of steroid receptors. Proc Natl Acad Sci USA 90: 99499953.
  • 53
    VanderKuur JA, Wiese TE, Brooks SC. 1993. Influence of estrogen structure on nuclear binding and progesterone receptor induction by the receptor complex. Biochemistry 32: 70027008.
  • 54
    Lewis DFV, Parker MG, King RJB. 1995. Molecular modelling of the human estrogen receptor and ligand interactions based on site-directed mutagenesis and amino acid sequence homology. J Steroid Biochem Mol Biol 52: 5565.
  • 55
    Waller CL, Juma BW, Gray LE Jr, Kelce WR. 1996. Three-dimensional quantitative relationships for androgen receptor ligands. Toxicol Appl Pharmacol 137: 219227.
  • 56
    Wurtz JM, Bourguet W, Renaud JP, Vivat V, Chambon P, Moras D, Gronemeyer H. 1996. A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol 3: 8794.
  • 57
    Ankley G, Mekenyan O, Kamenska V, Schmieder P, Bradbury S. 2002. Reactivity profiles of ligands of mammalian retinoic acid receptors: A preliminary COREPA analysis. SAR/QSAR Environ Sci 13: 365377.
  • 58
    Mekenyan O, Nikolova N, Schmieder P. 2003. Dynamic 3D QSAR techniques: Applications in toxicology. J Mol Struct 622: 147165.
  • 59
    Hurst T. 1994. Flexible 3-D searching: The directed tweak technique. J Chem Inf Comp Sci 34: 90196.